Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/04/2003EP1315753A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315746A1 Codon optimised recombinant dermaphagoides allergens
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315522A2 Calycins
06/04/2003EP1315510A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
06/04/2003EP1315418A2 Cryopreservation of sperm
06/04/2003EP1315417A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
06/04/2003EP1315410A1 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase
06/04/2003EP1185624A4 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
06/04/2003EP1176993B1 Biostable polyurethane products
06/04/2003EP1135177B1 Porous composite matrix and the production and use thereof
06/04/2003EP1030676A4 Bonding of cartilaginous matrices using isolated chondrocytes
06/04/2003EP1025203A4 Impaired brca2 function in cells and non-human transgenic animals
06/04/2003EP0859838B1 Novel procollagens
06/04/2003EP0850298B1 Neural transplantation using pluripotent neuroepithelial cells
06/04/2003EP0765398B1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using
06/04/2003EP0719338B1 Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants
06/04/2003EP0716695B1 Human calcium channel compositions and methods using them
06/04/2003EP0656007B1 Delta opioid receptor genes
06/04/2003CN1422336A High fidelity reverse transcriptases and uses thereof
06/04/2003CN1422334A Ecdysone receptor-based inducible gene expression system
06/04/2003CN1422332A Human ovarian mesothelial cells and methods of isolation and uses thereof
06/04/2003CN1422281A G-protein coupled receptors
06/04/2003CN1421531A Prepn process of humanized monoclonal antibody resisting hepatitis B virus surface antigen
06/04/2003CN1421459A Humanized CD3-resisting monoclonal antibody
06/04/2003CN1421244A Application of osteogenic growth peptide in promoting bematogenesis
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110552C Method of extracorporeal cloning hemopoietic stem cell
06/04/2003CN1110551C External tissur culture method for producing large number of viable mint plants
06/04/2003CN1110550C Process for producing coenzyme Q10 with tobacco as raw material
06/03/2003US6573437 Acala variety using DNA which confers a phenotype (antibiotic/herbicide/glyphosate resistance); growing in a sucrose-free callus induction medium comprising glucose; transferring to a glucose-free, sucrose medium
06/03/2003US6573431 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
06/03/2003US6573430 Cen gene and a method for delaying flowering
06/03/2003US6573429 Of given sequence; tobacco dehydogenase; use in producing disease resistance/insect resistance; can use in biosynthesis of ectoine, betaine, and fatty acid
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573097 Method of fertilizing an avian egg in the shell
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573080 Buffalo green monkey kidney and a first type selected from human mucoepidermoid and lung carcinoma cells; detection of enterovirus
06/03/2003US6573078 Human immunodeficiency virus (HIV) protein fragments having antiviral activity; peptides derived from HIV transmembrane glycoprotein that inhibit HIV-induced cell-cell fusion; use for inhibition of enveloped viral infection
06/03/2003US6573075 Fumonisin detoxification compositions and methods
06/03/2003US6573070 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573041 Determining reactivation, induction and suppression of virus latency
06/03/2003US6572896 Administering a cobalt or gadolinium ion source; melanomas
06/03/2003US6572895 Treatment of congestive heart failure
06/03/2003CA2240454C Method for transforming indica rice
06/03/2003CA2217633C Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
06/03/2003CA2138997C Vaccine composition containing adjuvants
05/2003
05/30/2003WO2003044214A2 Methods and compositions in checkpoint signaling
05/30/2003WO2003044203A2 Homologous recombination vector, preparations and uses
05/30/2003WO2003044202A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003WO2003044189A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same
05/30/2003WO2003044186A2 Novel gene cluster of pederin biosynthesis genes
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044183A1 Interleukin-2 gene transferred lymphokine activated killer cells
05/30/2003WO2003044181A1 Improvement of viability and function of pancreatic islets
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044169A2 Compositions and methods for reversibly inducing continual growth in normal cells
05/30/2003WO2003044164A2 Cell substrates and methods of use thereof
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044158A1 Methods and devices for the integrated discovery of cell culture environments
05/30/2003WO2003044057A2 Use of obg3 for promoting central nervous system remyelination
05/30/2003WO2003044051A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003WO2003044049A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003WO2003044048A2 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003WO2003044045A2 Peptides promoting cell adherence, growth and secretion
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043675A1 Creation of tissue engineered female reproductive organs
05/30/2003WO2003043674A1 Augmentation of organ function
05/30/2003WO2003043571A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
05/30/2003WO2003043542A1 Ectocornea-like sheet and method of constructing the same
05/30/2003WO2003043486A2 Matrix for the production of tissue engineered ligaments, tendons and other tissue
05/30/2003WO2003027281A3 Pluripotent stem cells originating in skeletal muscle intestinal tissue
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003026691A3 Use of hmgb1 for the activation of dendritic cells
05/30/2003WO2003025164A3 A gene encoding cyclododecanone monooxygenase
05/30/2003WO2003020104A3 Method of treating systemic inflammatory response syndrome
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003014337A3 Fusion of cells
05/30/2003WO2003012076A3 Culture medium to improve the purity of myoblast cultures and method using same
05/30/2003WO2003011200A3 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003006055A3 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002098891A3 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor
05/30/2003WO2002092778A3 Device and method for three-dimensional spatial localization and functional interconnection of different types of cells